Paper Details 
Original Abstract of the Article :
The purpose of this study was to synthesize a series of delta-amide derivatives of the antitrypanosomal drug eflornithine (2,5-diamino-2-(difluoromethyl)pentanoic acid hydrochloride, DMFO, CAS 70052-12-9), to determine their physicochemical properties and to assess whether they convert to eflornithi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1055/s-0031-1296347

データ提供:米国国立医学図書館(NLM)

Oral Administration of Synthesized Delta-Amides of Eflornithine

This study ventures into the world of drug development, seeking ways to improve the delivery and effectiveness of eflornithine, a drug used to treat trypanosomiasis. It's like exploring a new route through the desert of drug development, searching for a more effective and efficient way to deliver the medicine. The researchers synthesized a series of delta-amide derivatives of eflornithine, hoping to improve its oral absorption. This is like seeking a way to navigate the desert with greater ease and efficiency. However, the results showed that these derivatives were not absorbed from the gastrointestinal tract or were not converted into eflornithine in vivo, suggesting that oral administration may not be a viable option for this drug.

A Search for a New Route

The study provides valuable insights into the challenges of drug development. It's a reminder that finding a successful route to deliver a drug can be a difficult and sometimes unpredictable journey. The researchers' findings highlight the need for further research into alternative delivery methods for eflornithine, such as topical or intravenous administration. This is like continuing to search for a new oasis in the desert, one that offers a more effective and convenient way to deliver the drug.

The Desert of Drug Development

This study underscores the importance of careful consideration and rigorous testing when developing new drugs. It's a reminder that the desert of drug development is vast and challenging, and that finding a successful path can be difficult. The researchers' findings highlight the need for continued research into alternative delivery methods for eflornithine, ensuring that this valuable drug can be used effectively and safely.

Dr.Camel's Conclusion

This study is a reminder that the desert of drug development can be a difficult journey, but it also highlights the importance of perseverance and innovation. The researchers' findings demonstrate the need for continued exploration and research to find new and effective ways to deliver drugs, especially those that have the potential to save lives. It's like finding a new pathway through the desert, one that leads to a better future for patients.

Date :
  1. Date Completed 2011-01-25
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

21175041

DOI: Digital Object Identifier

10.1055/s-0031-1296347

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.